Release: NIH researchers identify potential new antiviral drug for COVID-19
The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study by researchers at NIH.
NICHD issues Releases and Media Advisories to the news media. Science Updates and Spotlights explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement such as an initiative launch or a notable staff change. Director’s Corner posts are monthly updates from the NICHD director.